TrialScientific reports2022

Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).

Deena E Kuruvilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.